{{Rsnum
|rsid=1040288
|Gene=NR3C2
|Chromosome=4
|position=148126966
|Orientation=plus
|GMAF=0.4421
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=NR3C2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 28.3 | 56.6 | 15.0
| HCB | 55.5 | 36.5 | 8.0
| JPT | 55.8 | 41.6 | 2.7
| YRI | 12.9 | 52.4 | 34.7
| ASW | 10.5 | 52.6 | 36.8
| CHB | 55.5 | 36.5 | 8.0
| CHD | 50.0 | 37.0 | 13.0
| GIH | 22.8 | 54.5 | 22.8
| LWK | 19.1 | 46.4 | 34.5
| MEX | 32.8 | 46.6 | 20.7
| MKK | 17.9 | 46.2 | 35.9
| TSI | 37.3 | 40.2 | 22.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21471972
|Title=Inefficient arterial hypertension control in patients with metabolic syndrome and its link to renin-angiotensin-aldosterone system polymorphisms
}}
{{PMID Auto
|PMID=16451596
|Title=Use of susceptibility scoring in conjunction with the genotypic transmission disequilibrium test.
|OA=1
}}

{{PMID Auto
|PMID=24766650
|Title=Drug Addiction and Stress-Response Genetic Variability: Association Study in African Americans
}}
{{on chip | Affy GenomeWide 6}}